On August 21, Gralon Pharmaceuticals (301130.SZ) stated on the investor interaction platform that the company's approved products and research products in the registration process do not include monkeypox treatment drugs such as Tocilizumab.
西点药业(301130.SZ)：已获批准的产品及已进入注册进程的在研产品中未包含特考韦瑞等猴痘治疗药物
Xide Pharmaceutical (301130.SZ): Approved products and products under registration that are being researched do not include monkeypox treatment drugs such as Tekovir.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated